| abstract |
The compounds represented by formula (I), or their pharmaceutically acceptable salts, which are glycogen phosphorylase inhibitors and useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia, for example myocardial ischemia, |